Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Partners 4 Access

Partners 4 Access is listed as a small business research supplier in the Scientist.com network, with 2 sites in 2 countries.

View Partners 4 Access on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2
Countries 2

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Clinical Consulting

  • Patient Advocacy Help patients communicate with their healthcare providers so they get the information they need to make decisions about their health care.

HEOR

  • Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.

Market Access

  • Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
  • Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
  • Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
  • Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
  • Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
  • Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
Show all 14 in Market Access 8 more
  • Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
  • Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
  • Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
  • Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
  • Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
  • Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

  • Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
  • Communication Plan Communications plan enables organizations and corporations to effectively deliver information to appropriate stakeholders and customers.
  • KOL Engagement & Management Building and maintaining compliant, value-driven relationships with Key Opinion Leaders (KOLs) to collaborate on scientific exchange and clinical education initiatives.
  • Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
  • Payer Directed Communication Tools (other than Dossiers) Request services related to payer directed communication tools.
  • Scientific Platform Develop a rigorous approach to creating a core story (grounded in the scientific literature) for a product. This involves identifying core concepts that address disease states, clinical needs, and product-related...
Show all 51 services 37 more

Old Category HEOR, RWE, Market Access

  • Health Technology Assessment Submission (HTA Submission) (DUPLICATE) Conduct a multidisciplinary process that determines the value of a health technology through different points in its lifecycle.

Primary Market Research

  • Asset Prioritization Studies Assesses stakeholder interest and unmet need across multiple assets in development. Helps pipeline teams allocate investment and identify lead candidates.
  • Brand Tracking and Awareness Monitors brand familiarity, favorability, and performance over time among target audiences. Used to guide campaign adjustments and market strategy.
  • Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.
  • Cross-Functional Readouts and Workshops Interactive sessions to share findings and align stakeholders across functions. Enhances cross-team decision-making and execution planning.
  • Digital Journey Explores the online behaviors and decision-making patterns of stakeholders. Informs digital strategy, content placement, and platform selection.
  • Early Concept Testing Evaluates initial ideas or positioning strategies with target audiences before refinement. Provides go/no-go input and direction for further development.
Show all 27 in Primary Market Research 21 more
  • Endpoint Relevance Testing Tests how meaningful proposed trial endpoints are to stakeholders, especially payers and regulators. Informs protocol refinement and evidence strategy.
  • Focus groups (in-person/virtual) Facilitated group discussions to evaluate reactions to concepts, messages, or services. Produces consensus insights and contrasting views used to refine strategy, materials, or offerings.
  • Generalists and specialists (e.g., oncologists, neurologists) Research targeting both broad-practice physicians and specialists to understand treatment preferences, diagnostic challenges, and clinical decision-making. Provides comparative insights for segmentation, messaging...
  • In-depth interviews (IDIs) One-on-one qualitative interviews conducted with key stakeholders to explore beliefs, decision drivers, and unmet needs. Delivers rich narrative data to inform trial design, product positioning, and message development.
  • Iterative concept/message testing with interim adjustments Tests concepts or materials in cycles with refinements after each round based on feedback. Delivers optimized content that evolves with stakeholder input.
  • Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
  • Launch Readiness Assessments Evaluates internal and external preparedness for product launch, including sales force, market awareness, and access environment. Identifies gaps and supports launch planning.
  • Lifecycle Extension Concept Testing Tests ideas for extending the commercial life of a product (e.g., new formulations, indications). Supports long-term planning and investment decisions.
  • Market Opportunity Assessments Quantifies addressable market size, unmet needs, and competitive landscape. Supports go/no-go decisions and commercial forecasting.
  • Message / Claims testing Iterative research to assess clarity, relevance, and impact of key messages. Delivers validated communications that align with stakeholder expectations.
  • Online/phone surveys Quantitative questionnaires deployed via web or telephone to gather feedback from large, targeted populations. Results offer statistically significant insights for trend analysis, segmentation, and tracking.
  • Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
  • Pharmacy and Therapeutics (P&T) Committee Members - Market Research Research with formulary decision-makers to understand access requirements, value perceptions, and evidence expectations. Guides dossier development and value communication.
  • Policy Influencers - Market Research Qualitative or quantitative research with stakeholders who shape or advise on healthcare policy. Supports early stakeholder mapping and access scenario planning.
  • Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.
  • Product Landscape and Unmet Needs Reports Synthesizes secondary data and expert input into landscape maps and gap analyses. Informs asset development and positioning.
  • Strategic Recommendations for Brand Teams Delivers synthesized insights and data-driven strategic guidance to commercial teams. Supports brand planning and lifecycle management.
  • Target Product Profile (TPP) Testing Tests stakeholder reactions to hypothetical product profiles across key attributes. Guides clinical development prioritization and access positioning.
  • Touchpoint Analysis Maps where and how stakeholders interact with a brand or service across the journey. Identifies high-impact opportunities for engagement.
  • Trial Feasibility and Design Preference (HCP/patient) Gathers stakeholder input on protocol practicality, site selection, and enrollment design. Reduces recruitment barriers and aligns trials with real-world practice.
  • Unmet Need and SoC Validation Assesses perceived gaps in current standards of care and the need for new interventions. Supports value proposition development and market shaping.

Real World Evidence & Data

  • Payer Outcomes-Based Contract Trial Study or analysis of data (claims, electronic HR/MR) to assess reimbursement or price to actual health outcomes.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • Netherlands Maastricht 1 site
  • United Kingdom London 1 site

Source: Scientist.com supplier network (site locations)

Get the Partners 4 Access report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Partners 4 Access on Scientist.com

For prices, more details, or to contact Partners 4 Access, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.